SCHEDULE: Wasatch Advisors LP Discloses 10% Stake in Journey Medical Corp

Wasatch Advisors LP has reported beneficial ownership of 2,133,370 shares, representing 10.0% of the outstanding common stock of Journey Medical Corp.

Summary

• Wasatch Advisors LP, an investment adviser, has filed a Schedule 13G, indicating it beneficially owns 2,133,370 shares of Journey Medical Corp. common stock.
• This ownership stake represents 10.0% of the class of securities.
• The filing details sole voting power for 1,979,366 shares and sole dispositive power for 2,133,370 shares.
• The filing date is March 31, 2026, with the certification signed on April 6, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates significant institutional interest but does not provide operational or financial performance details.

Positives

• Wasatch Advisors LP has taken a significant stake, holding 10.0% of Journey Medical Corp.'s common stock, suggesting confidence in the company's prospects.
• The reporting entity, Wasatch Advisors LP, is an investment adviser, implying the investment is made with a professional investment strategy.

Future Outlook

No specific forward-looking statements or guidance are provided in this Schedule 13G filing, which is primarily an ownership disclosure.

Industry Context

StockSavvy.ai notes that significant stake acquisitions by institutional investors like Wasatch Advisors LP often signal a belief in the target company's growth potential or undervaluation within its sector.

Stakeholder Impact

• Shareholders may view the increased institutional ownership positively, potentially leading to greater market interest and liquidity.
• The investment by Wasatch Advisors LP could signal confidence to other potential investors.

Key Dates

Recommendation

The filing indicates a significant institutional investment, suggesting a positive outlook from Wasatch Advisors LP. However, without further operational or financial details from Journey Medical Corp., a 'hold' recommendation is prudent, awaiting more comprehensive company performance data.

Keywords

Journey Medical Corp, Wasatch Advisors LP, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, SEC Filing